Professional Biotechnology Solutions
Supporting Scientific Research Innovation and Industrial Development

Yantai Huaxin Synthetic Biotechnology Co., Ltd., founded in 2022, is a high‑tech enterprise deeply engaged in the fields of peptide drugs and chemical drugs. The company focuses on the R&D, production, sales, and implementation of peptide solid‑phase synthesis carrier resins, microsphere‑related products, and technical services, providing end‑to‑end solutions for research institutions and corporate clients worldwide.

The company has strong capabilities, equipped with a professional R&D team and a well‑equipped R&D center, and has built both laboratory‑scale and pilot‑scale facilities as well as large‑scale production bases. Dedicated production workshops have been established for small‑molecule APIs, peptide solid‑phase synthesis carrier resins, and gel separation media, forming a closed loop from technology development to mass delivery and providing a solid foundation for implementing core business.

In the technical domain, the company has been deeply involved for many years and has brought together senior experts in microsphere‑based solid‑phase synthesis technologies, focusing on full‑chain technological innovation in microsphere preparation, with particularly strong advantages in equipment development and process design. We introduce advanced basic equipment from both domestic and overseas sources and independently develop microsphere preparation systems adapted to different systems, building a complete equipment portfolio from laboratory trials to industrial‑scale production. Guided firmly by R&D, we closely follow global cutting‑edge technologies to ensure a leading position in peptide solid‑phase synthesis and microsphere preparation.

Our core business focuses on three major segments:

1.  Equipment R&D and manufacturing: focusing on supporting equipment for peptide solid‑phase synthesis carrier resins, as well as membrane emulsification equipment for preparing stable emulsions, microspheres, and microcapsules with uniform and controllable particle size. This covers laboratory‑scale membrane emulsifiers, pilot‑scale membrane emulsification systems, and customized industrial‑scale microsphere production and scale‑up equipment;

2.  Customized product supply: providing high value‑added customized microsphere products that meet the individualized needs of different industries and application scenarios;

3.  End‑to‑end technical services: providing industrial‑grade microsphere preparation solutions for various microspheres (emulsions, microcapsules), including professional process and technical services such as equipment configuration, parameter optimization, and process design, as well as equipment selection, customized modification, and production line construction.

With continuous technological innovation and high‑quality services, the company has established long‑term and stable cooperative relationships with many research institutions worldwide. Our customers span numerous countries and regions including Europe, the United States, and Canada. We provide high‑quality peptide solid‑phase synthesis carrier resins, microsphere (emulsion) products, and end‑to‑end solutions for universities, research institutes, and enterprises. Looking ahead, the company will continue to uphold the spirit of innovation, deepen its core business areas, and contribute further to technological upgrading and industrial development across the industry.